Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment

This publication has 19 references indexed in Scilit:

• Effect of High-Dose Statin Treatment on Plasma Concentrations of Endogenous Nitric Oxide Synthase Inhibitors
  Journal of Cardiovascular Pharmacology, 2003
• Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X
  The American Journal of Cardiology, 2002
• Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical NG, NG-dimethylarginine in human essential hypertension1
  American Journal of Hypertension, 2002
• Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine
  The Lancet, 2001
• Contemporary Diagnosis and Management of Unstable Angina
  Mayo Clinic Proceedings, 2000
• Novel Mechanism for Endothelial Dysfunction
  Circulation, 1999
• Endogenous Nitric Oxide Synthase Inhibitor
  Circulation, 1999
• L-Arginine Enhances Functional Recovery and Ca2+-Dependent Nitric Oxide Synthase Activity After Ischemia and Reperfusion in the Rat Heart
  Journal of Cardiovascular Pharmacology, 1997
• Simultaneous determination of low plasma concentrations of retinol and tocopherols in preterm infants by a high-performance liquid chromatographic micromethod
  Journal of Chromatography B: Biomedical Sciences and Applications, 1997
• Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium.
  Circulation Research, 1993